• Medartis expects 2026 organic core revenue growth to exceed its 17%-19% constant-currency forecast if current demand holds.
• Higher sales would lift the core EBITDA margin to the upper end of guidance in the high teens.
• Faster U.S. TOUCH adoption underpins expectations for about 3,000 procedures this year versus more than 2,000 through October.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Medartis Holding AG published the original content used to generate this news brief via EQS News (Ref. ID: adhoc_2425856_de) on November 02, 2026, and is solely responsible for the information contained therein.